MétaCan
← all works

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

2016· review· en· 2,995 citations· W2486629951 on OpenAlex· 10.1016/s1470-2045(16)30206-6

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
The Lancet Oncology
Topic
Multiple Myeloma Research and Treatments
Field
Medicine
Canadian institutions
Dalhousie University
Funders
Keywords
Multiple myelomaMinimal residual diseaseMedicineBone marrowMyeloma proteinClinical trialDiseaseOncologyMonoclonalInternal medicineMonoclonal antibodyImmunologyAntibody
Has abstract in OpenAlex
no